Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $303.3M | $296.7M | $318.6M | $326.6M | $312.7M | $302.0M | $336.5M | $441.1M | $623.6M | $601.9M | $714.6M | $806.2M | $882.1M | $1,041.2M | $975.8M | $963.0M | $943.4M | $1,086.8M | $1,127.7M | $1,125.4M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Prestige Consumer Healthcare Inc.'s last 12-month Revenue is $1,110.4M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Prestige Consumer Healthcare Inc.'s Revenue growth was (1.5%). The average annual Revenue growth rates for Prestige Consumer Healthcare Inc. have been 5.6% over the past three years, 3.1% over the past five years.
Over the last year, Prestige Consumer Healthcare Inc.'s Revenue growth was (1.5%), which is lower than industry growth of 0.0%. It indicates that Prestige Consumer Healthcare Inc.'s Revenue growth is Bad.